Living with Diabetes? Check out our site for you

Healthcare professional? This is your dedicated site.



NEW! The Guardian Connect CGM System. The only Smart CGM system.

The ONLY Smart CGM system that helps patients on multiple daily injections(MDI) outsmart highs and lows. Using smart technology to predict where glucose levels are headed, the system alerts patients from 10 to 60 minutes before a glucose excursion, so they can take action in advance.

Now available with Guardian Sensor 3 for age 2 and above and Enlite Sensor for age 7 and above.


Without the full picture,
Diabetes can be unpredictable

for patients on Insulin Injections.


The only CGM system that can alert your patients of potential highs and lows up to 60 minutes in advance.

In a recent Carelink analysis of real-world data, it was found that Guardian Connect system users§avoided 60% of low and 39% of high glucose episodes.



Patients may avoid lows and highs4-before they happen

The Guardian Connect CGM system monitors glucose1 levels day and night, sending precise readings automatically to the app.

Guardian Sensor 3

The system includes a small sensor that can be worn up to seven days and a slim, discreet Bluetooth® transmitter that can be worn in almost any situation. They work together to send precise glucose readings every five minutes.

Medtronic’s (real-time) continuous glucose monitoring (CGM) products are indicated for use by people living with type one diabetes.

Guardian Sensor 3 may be used as part of the Guardian Connect and MiniMed® 640G systems for ages 2 and up. Sensor is indicated for use on arm and abdomen. Guardian Sensor 3 may also be used as part of the MiniMed® 670G system for people living with type 1 diabetes age 7 and up. Sensor is indicated for use on abdomen only.

Meet Sara
Social Media Influencer
Living with Type 1 Diabetes

Experience Automatic
Uploads to Carelink System.


  • With up to 288 sensor glucose readings a day5, the Guardian™ Connect system uncovers significantly more data about your patients’ daily glucose patterns than blood glucose monitoring (BGM) alone.
  • When patients link their Carelink™ account to your practice, you can seamlessly access their most recent CGM data right on the Carelink™ website.




Clinical references † Cohen O, et al. Avoidance of Glucose Excursions by the Guardian™ Connect CGM system – real world Poster presented at Advanced Technologies & Treatments for Diabetes conference; 2018 February 14-18, Vienna, Austria. data. 1 Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: Clinical decisions and glycemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care. 2001;24(12):2030 –2034. 2 American Association of Clinical Endocrinologists and American College of Endocrinology 2016 outpatient glucose monitoring consensus statement 3 Gonder-Frederick La, et al. Self-measurement of blood glucose. Accuracy of self-reported data and adherence to recommended regimen. Diabetes Care. 1988 jul-aug;11(7):579-85. dQ&A Diabetes Educator Perspectives Survey, Q3 2015. 428 total respondents. Indications The Guardian Connect app is intended for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in persons with diabetes mellitus. The Guardian Connect app is intended for use with a compatible consumer mobile electronic device. It allows users to track patterns in glucose concentrations and to possibly identify episodes of low and high glucose. The Guardian Connect app displays alerts if a glucose level reaches, falls below, or rises above set values. Sensor glucose values displayed on the screen are not intended to be used directly for making therapy adjustments, but rather to provide an indication of when a meter blood glucose measurement may be required. Warnings Important Safety Information: Guardian® Connect CGM System The Guardian Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (age 2 and up) with diabetes mellitus. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at For proper instructions on inserting the Guardian® Sensor 3, visit the support webpage for inserting your sensor. © 2018 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic™. Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.